News
With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations ...
"This is a real concern for all patients who have been benefiting from this medicine. There will be panic and hysteria out ...
There’s a new kind of nosy parker on the rise in the United States, a person who thinks it’s fine to blurt out “Are you on ...
Thousands of overweight people are to be prescribed low-calorie soups and shakes on the NHS in a radical bid to tackle ...
It’s no secret that obesity is becoming an epidemic in the United States. It’s estimated that by 2030, 50 percent of ...
Weight-loss jabs had an alarming impact on my mental health. I was prepared for nausea and diarrhoea, but not depression and ...
Wall Street loves a dominant player, and Eli Lilly (NYSE: LLY) looks unstoppable with its obesity blockbusters printing money ...
Eli Lilly Vs. Novo Nordisk: Correction Overly Done - GLP-1 Market Leadership/ Robust Pipelines Ahead
Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...
As the cost of Mounjaro jabs is set to increase by as much as 170 per cent, Jade Kay, who has already spent £2.4k on the drug ...
Two new studies that have been published recently show that people who have been taking weight loss drugs may have ...
WITH the price of Mounjaro set to rise and concerns about long-term affordability and access, many may be looking to turn to alternative treatments, like Wegovy. But how do the two weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results